Tyrx produces antibacterial pouches, or envelopes, for medical devices to reduce risk of infection following device implantation. The company’s main product is the AIGISRx Antibacterial Envelope, which is placed around implants prior to implantation and eventually dissolve after releasing antimicrobial agents.
Tyrx’s pouches have been cleared to use with spinal cord stimulators and cardiac implants.
More Articles on Devices:
19 Spine Devices Receive FDA 510(k) Clearance in December
DePuy Synthes Spine Launches Bone Matrix Tissue Implant for Spinal Fusion
SI-BONE Celebrates 10k iFuse Implant System Uses Worldwide
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
